Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsBusiness

Coronavirus treatment: Patanjali to share outcome of clinical trial of its COVID-19 drug, claims 'major breakthrough'

In an earlier interaction Balkrishna told Moneycontrol that the company had launched clinical trials on humans to find a cure for COVID-19 after receiving regulatory approvals.

June 24, 2020 / 09:29 PM IST

Patanjali Ayurvedic Medicines has announced that it will disclose the outcome of its controlled clinical trial of randomised placebo on COVID-19 patients.

The research was jointly conducted by the Patanjali Research Institute, Haridwar and the National Institute of Medical Science, Jaipur.

Co-founder Baba Ramdev and Managing Director Acharya Balkrishna will address the media at 12 noon on June 23 (today), to share “the major breakthrough in cure of COVID-19,” the company said. The team of scientist, researchers and doctors involved in the trials will also be present at the video conference.

Medicines from the research are being manufactured by Divya Pharmacy, Haridwar and Patanjali Ayurved, Haridwar, it added.